Eckhardt Sue Gail Insider Trades

Insider Trading History

Track insider trading activity for Eckhardt Sue Gail. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Exelixis
Exelixis EXEL
Director
Holding Value $1.33M 25,891 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$419k 8,367 shares
$50.03
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $900k 17,524 shares
Last Trade
Feb 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$169k 3,856 shares
$43.79
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $1.1M 21,384 shares
Last Trade
Jun 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$805k 18,838 shares
$42.74
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $2.06M 40,218 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$418k 9,812 shares
$42.60
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $1.19M 23,136 shares
Last Trade
Feb 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 7,712 shares
$35.00
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $1.76M 34,262 shares
Last Trade
Feb 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$405k 11,568 shares
$35.02
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $2.15M 41,974 shares
Last Trade
Feb 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 7,712 shares
$35.00
$51.34
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.6 16,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 6,000 shares
$5.30
$0.00
Exelixis
Exelixis EXEL
Director
Holding Value $1.76M 34,262 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$409k 18,838 shares
$21.69
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $1.58M 30,848 shares
Last Trade
Jan 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$717k 30,848 shares
$23.24
$51.34
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.2 12,000 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2k 6,000 shares
$3.70
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.2 12,000 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7k 20,000 shares
$0.73
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.75 17,500 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.3k 35,000 shares
$0.78
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $1.75 17,500 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$110k 17,500 shares
$6.30
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $3.5 35,000 shares
Last Trade
Sep 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$313k 35,000 shares
$8.94
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up